Literature DB >> 20863206

Nighttime hospital blood pressure--a predictor of death, ESRD, and decline in GFR.

Paul E Drawz1, Noah Rosenthal, Denise C Babineau, Mahboob Rahman.   

Abstract

Nighttime systolic blood pressure (BP) from ambulatory blood pressure monitoring (ABPM) is more predictive than clinic BP for cardiovascular disease, stroke, and death even after controlling for clinic BP. However, ABPM is expensive and burdensome to obtain regularly. BPs obtained in the hospital may provide a window into nighttime BP. We conducted a retrospective cohort study of all hypertensive patients admitted to the Louis Stokes Cleveland Department of Veterans Affairs Medical Center (LSCDVAMC) in 2002 and 2003 with one or more BP recorded between midnight and 6 am on the day of or the day before discharge. The mean age of the study population (n = 1085) was 62 years and 96% were male. Twenty-two percent had coronary artery disease (CAD) and 34% had diabetes. The mean nighttime systolic BP was 132 mmHg and baseline glomerular filtration rate (GFR) was 83 mL/min per 1.73 m(2). Over a median follow-up period of 4.3 years, 266 subjects died, 22 developed end-stage renal disease (ESRD), 99 had a 50% decline in GFR, and 136 developed myocardial infarction (MI). The adjusted hazard ratios (HRs) associated with a 10 mmHg increase in nighttime systolic BP were 1.03 (95% confidence interval, 0.93-1.15) for death, 1.30 (0.94-1.80) for ESRD, 1.26 (1.08-1.47) for a 50% decline in GFR, 1.07 (0.92-1.23) for myocardial infarction, and 1.12 (1.03-1.23) for a composite of death, ESRD, or a 50% decline in GFR. In conclusion, nighttime systolic BP in hospitalized patients is an independent predictor of important clinical outcomes such as a composite of death, ESRD, or a 50% decline in GFR.

Entities:  

Mesh:

Year:  2010        PMID: 20863206      PMCID: PMC3146017          DOI: 10.3109/0886022X.2010.510615

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  43 in total

1.  Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: the Ohasama study.

Authors:  T Ohkubo; A Hozawa; K Nagai; M Kikuya; I Tsuji; S Ito; H Satoh; S Hisamichi; Y Imai
Journal:  J Hypertens       Date:  2000-07       Impact factor: 4.844

2.  Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study.

Authors:  Takayoshi Ohkubo; Atsushi Hozawa; Junko Yamaguchi; Masahiro Kikuya; Kaori Ohmori; Mari Michimata; Mitsunobu Matsubara; Junichiro Hashimoto; Haruhisa Hoshi; Tsutomu Araki; Ichiro Tsuji; Hiroshi Satoh; Shigeru Hisamichi; Yutaka Imai
Journal:  J Hypertens       Date:  2002-11       Impact factor: 4.844

3.  Autonomic nervous system activity in dipper and non-dipper essential hypertensive patients. What about sex differences?

Authors:  S Ragot; D Herpin; J P Siché; P Ingrand; J M Mallion
Journal:  J Hypertens       Date:  1999-12       Impact factor: 4.844

4.  Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men.

Authors:  Kristina Björklund; Lars Lind; Björn Zethelius; Bertil Andrén; Hans Lithell
Journal:  Circulation       Date:  2003-03-11       Impact factor: 29.690

5.  Assessment of vital status in Department of Veterans Affairs national databases. comparison with state death certificates.

Authors:  J A Dominitz; C Maynard; E J Boyko
Journal:  Ann Epidemiol       Date:  2001-07       Impact factor: 3.797

6.  Accuracy of computerized outpatient diagnoses in a Veterans Affairs general medicine clinic.

Authors:  Herbert C Szeto; Robert K Coleman; Parisa Gholami; Brian B Hoffman; Mary K Goldstein
Journal:  Am J Manag Care       Date:  2002-01       Impact factor: 2.229

7.  Non-dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients.

Authors:  Manchang Liu; Hiroshi Takahashi; Yoshiki Morita; Shoichi Maruyama; Masashi Mizuno; Yukio Yuzawa; Midoriko Watanabe; Takanobu Toriyama; Hirohisa Kawahara; Seiichi Matsuo
Journal:  Nephrol Dial Transplant       Date:  2003-03       Impact factor: 5.992

8.  Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension.

Authors:  P Verdecchia; G Schillaci; M Guerrieri; C Gatteschi; G Benemio; F Boldrini; C Porcellati
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

9.  Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes.

Authors:  Empar Lurbe; Josep Redon; Ajit Kesani; Jose Maria Pascual; Jose Tacons; Vicente Alvarez; Daniel Batlle
Journal:  N Engl J Med       Date:  2002-09-12       Impact factor: 91.245

10.  Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events.

Authors:  P Verdecchia; G Schillaci; C Gatteschi; I Zampi; M Battistelli; C Bartoccini; C Porcellati
Journal:  Circulation       Date:  1993-09       Impact factor: 29.690

View more
  10 in total

Review 1.  Is nocturnal blood pressure reduction the secret to reducing the rate of progression of hypertensive chronic kidney disease?

Authors:  Rupal Mehta; Paul E Drawz
Journal:  Curr Hypertens Rep       Date:  2011-10       Impact factor: 5.369

Review 2.  Blood pressure measurement: clinic, home, ambulatory, and beyond.

Authors:  Paul E Drawz; Mohamed Abdalla; Mahboob Rahman
Journal:  Am J Kidney Dis       Date:  2012-04-21       Impact factor: 8.860

3.  Pharmacist-based antihypertensive medication review and assignment of morning versus evening dosing of once-daily antihypertensive medications: A pilot study to assess feasibility and efficacy in chronic kidney disease patients.

Authors:  Julia R Smith; Lisa Hillman; Paul E Drawz
Journal:  Clin Exp Hypertens       Date:  2017-12-06       Impact factor: 1.749

Review 4.  Nocturnal medications dosing: does it really make a difference in blood pressure control among patients with chronic kidney disease?

Authors:  Salman Rasheed Mallick; Mahboob Rahman
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

5.  Association between shiftwork and glomerular filtration rate in police officers.

Authors:  Luenda E Charles; Ja K Gu; Desta Fekedulegn; Michael E Andrew; John M Violanti; Cecil M Burchfiel
Journal:  J Occup Environ Med       Date:  2013-11       Impact factor: 2.162

6.  Effect of the Nonsteroidal Mineralocorticoid Receptor Blocker, Esaxerenone, on Nocturnal Hypertension: A Post Hoc Analysis of the ESAX-HTN Study.

Authors:  Kazuomi Kario; Sadayoshi Ito; Hiroshi Itoh; Hiromi Rakugi; Yasuyuki Okuda; Motonobu Yoshimura; Satoru Yamakawa
Journal:  Am J Hypertens       Date:  2021-05-22       Impact factor: 2.689

7.  Nighttime Systolic Blood-Pressure Load Is Correlated with Target-Organ Damage Independent of Ambulatory Blood-Pressure Level in Patients with Non-Diabetic Chronic Kidney Disease.

Authors:  Cheng Wang; Jun Zhang; Wenjie Deng; Wenyu Gong; Xun Liu; Zengchun Ye; Hui Peng; Tanqi Lou
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

8.  Cross-sectional study on the relationship between the level of serum cystatin C and blood pressure reverse dipping in hypertensive patients.

Authors:  Jin Han; Ya Gao; Qi Guo; Dan Su; Bin Yan; Liyuan Peng; Yuxing Du; Ke Li; Gang Wang
Journal:  BMJ Open       Date:  2016-09-02       Impact factor: 2.692

9.  Supine blood pressure-A clinically relevant determinant of vascular target organ damage in hypertensive patients.

Authors:  Janis M Nolde; Márcio Galindo Kiuchi; Revathy Carnagarin; Shaun Frost; Dennis Kannenkeril; Leslie Marisol Lugo-Gavidia; Justine Chan; Anu Joyson; Vance B Matthews; Lakshini Y Herat; Omar Azzam; Markus P Schlaich
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-12-03       Impact factor: 3.738

10.  Reversed dipper blood-pressure pattern is closely related to severe renal and cardiovascular damage in patients with chronic kidney disease.

Authors:  Cheng Wang; Jun Zhang; Xun Liu; Cuicui Li; Zengchun Ye; Hui Peng; Zhujiang Chen; Tanqi Lou
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.